E
Emilie Thibaudeau
Publications - 30
Citations - 456
Emilie Thibaudeau is an academic researcher. The author has contributed to research in topics: Hyperthermic intraperitoneal chemotherapy & Oxaliplatin. The author has an hindex of 10, co-authored 26 publications receiving 275 citations.
Papers
More filters
Journal ArticleDOI
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
D. Goéré,D. Goéré,Olivier Glehen,François Quenet,Jean-Marc Guilloit,J.M. Bereder,Gérard Lorimier,Emilie Thibaudeau,Laurent Ghouti,Amandine Pinto,Jean-Jacques Tuech,Reza Kianmanesh,Michel Carretier,Frédéric Marchal,Catherine Arvieux,Cécile Brigand,Pierre Meeus,Patrick Rat,S. Durand-Fontanier,Pascale Mariani,Zaher Lakkis,Valeria Loi,Nicolas Pirro,Charles Sabbagh,M. Texier,Dominique Elias,M. Ducreux,David Malka,Valérie Boige,Ellen Benhamou +29 more
TL;DR: Systematic second-look surgery plus oxaliplatin-HIPEC did not improve disease-free survival compared with standard surveillance and essential surveillance of patients at high risk of developing colorectal peritoneal metastases appears to be adequate and effective in terms of survival outcomes.
Journal ArticleDOI
Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study
Vahan Kepenekian,Dominique Elias,Guillaume Passot,Eliane Mery,Diane Goéré,D. Delroeux,François Quenet,G. Ferron,Denis Pezet,Jean-Marc Guilloit,Pierre Meeus,Marc Pocard,J.M. Bereder,Karine Abboud,Catherine Arvieux,Cécile Brigand,Frédéric Marchal,J-M Classe,Gérard Lorimier,C. de Chaisemartin,Frédéric Guyon,Pascale Mariani,Pablo Ortega-Deballon,S. Isaac,C. Maurice,F. N. Gilly,Olivier Glehen,Gerlinde Averous,Frédéric Bibeau,D. Bouzard,A. Chevallier,S. Croce,Peggy Dartigues,S. Durand-Fontanier,L. Gouthi,Bruno Heyd,R. Kaci,R. Kianmanesh,M. H. Laverrière,Eric Leblanc,B. Lelong,A. Leroux,V. Loi,Christophe Mariette,S. Msika,P. Peyrat,Nicolas Pirro,J. Paineau,F. Poizat,Jack Porcheron,P. Rat,J.-M. Regimbeau,Emilie Thibaudeau,Jean-Jacques Tuech,S. Valmary-Degano,V. Verriele,Philippe Zerbib,Franck Zinzindohoué +57 more
TL;DR: In this paper, the authors evaluated the impact of perioperative systemic chemotherapy strategies on survival and postoperative outcomes in patients with DMPM treated with curative intent with CRS-HIPEC, using a multi-institutional database: the French RENAPE network.
Journal ArticleDOI
A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application
Laurent Villeneuve,A. Thivolet,Naoual Bakrin,Faheez Mohamed,S. Isaac,Pierre-Jean Valette,Olivier Glehen,P. Rousset,Julio Abba,Karine Abboud,Catherine Arvieux,G. Balague,V. Barrau,Houda Ben Rejeb,J.M. Bereder,Frédéric Bibeau,D. Bouzard,Cécile Brigand,S. Carrere,M. Carretier,C. de Chaisemartin,M. Chassang,A. Chevallier,Thomas Courvoisier,Peggy Dartigues,D. Delroeux,G. Desolneux,A. Dohan,Clarisse Dromain,Frédéric Dumont,S. Durand-Fontanier,Dominique Elias,Clarisse Eveno,S. Evrard,O. Fay,G. Ferron,D. Geffroy,François-Noël Gilly,Julien Fontaine,Nicolas Goasguen,L. Ghouti,Diane Goéré,Jean-Marc Guilloit,Frédéric Guyon,Bruno Heyd,R. Kaci,Mehdi Karoui,R. Kianmanesh,C. Labbé,J. Lacroix,G. Lang-Averous,M. H. Laverrière,Jérémie H. Lefevre,B. Lelong,A. Leroux,Rea Lo Dico,V. Loi,Gérard Lorimier,Frédéric Marchal,A. Mariani,Pascale Mariani,Christophe Mariette,Pierre Meeus,E. Mery,M. Messager,S. Msika,Cédric Nadeau,Pablo Ortega-Deballon,Guillaume Passot,C. Petorin,P. Peyrat,Denis Pezet,Guillaume Piessen,Nicolas Pirro,Marc Pocard,F. Poizat,Jack Porcheron,G. Pourcher,François Quenet,P. Rat,Jean-Marc Regimbeau,P. Rousselot,Charles Sabbagh,Magali Svrcek,R. Tetreau,Emilie Thibaudeau,Jean-Jacques Tuech,S. Valmary-Degano,Delphine Vaudoyer,S. Velasco,V. Verriele-Beurrier,Romuald Wernert,Franck Zinzindohoué +92 more
TL;DR: This application offers computer-assistance to produce simple, quick but precise and standardized pre, intra and postoperative reports of the extent of peritoneal metastases and may help specialized and non-specialized institutions in their current practice but also facilitate research and multicentre studies on peritoneAL surface malignancies.
Journal ArticleDOI
The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression.
Juliette Eugene,Nicolas Jouand,Kathleen Ducoin,Delphine Dansette,Romain Oger,Cécile Deleine,Edouard Leveque,Guillaume Meurette,Juliette Podevin,Tamara Matysiak,Jaafar Bennouna,Stéphane Bézieau,Christelle Volteau,Wassila El Alami Thomas,Jerome Chetritt,Olivier Kerdraon,Pierre Fourquier,Emilie Thibaudeau,Frédéric Dumont,Jean-François Mosnier,Claire Toquet,Anne Jarry,Nadine Gervois,Céline Bossard +23 more
TL;DR: It is suggested that HLA-E/β2m–CD94/NKG2A represents a new druggable inhibitory immune checkpoint, preferentially expressed in microsatellite instable tumors, but also in a subgroup of micros Satellite stable tumors, leading to a new opportunity in colorectal cancer immunotherapies.
Journal ArticleDOI
Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.
Frédéric Dumont,Hélène Senellart,F Pein,Loïc Campion,Olivier Glehen,Diane Goéré,Marc Pocard,Emilie Thibaudeau +7 more
TL;DR: The aim is to determine the maximum tolerated dose of pressurized oxaliplatin administered by the intraperitoneal route (PIPAC) during two consecutive procedures at a 4–6 week interval for patients with extended peritoneal carcinomatosis from the gastrointestinal tract.